Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Nuclear Medicine|February 16, 2026
Remarkable Response to 177Lu-PSMA and 177Lu-DOTA-IBA Cocktail Therapy in a Patient With Dual Primary MalignanciesChunmei Tian, Li-Bo Xie, Zhiqiao Liu, et al.
Clinical Nuclear Medicine|February 3, 2026
A case of sarcomatoid carcinoma of the lung treated with a new radiopharmaceutical 225Ac-DOTA-IBAXiangting Liu, Yueqi Zhao, Chunmei Tian, et al.
Clinical Nuclear Medicine|April 1, 2026
Efficacy of 177Lu-FAP-2286 and 225Ac-FAP-2286 in Treating Pancreatic Adenocarcinoma With Lymph Node MetastasisChunmei Tian, Lixian Mou, Tingting Xu, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|October 5, 2021
MiRNA-29a serves as a promising diagnostic biomarker in children with temporal lobe epilepsy and regulates seizure-induced cell death and inflammation in hippocampal neuronsYifei Wu, Yanrui Zhang, Shuxia Zhu, et al.
Turkish Journal of Medical Sciences|June 19, 2015
Effect of keratinocyte growth factor on growth and transdifferentiation of primary alveolar epithelial type II cellsXiuxiang Liu, Zhichun Feng, Chunmei Tian, et al.
Cancer Biomarkers : Section a of Disease Markers|April 26, 2018
Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemiaChunmei Tian, Lin Zhang, Xiaohua Li, et al.
Clinical Nuclear Medicine|August 3, 2026
177Lu-FAP-2286 Targeted Radionuclide Therapy in Advanced Pancreatic Cancer: A Real-World Retrospective Salvage StudyTingting Xu, Chunmei Tian, Hongyu Yang, et al.
Pageof 2